Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,908,237
+$29,207 QoQ
Shares Held
27,201
-3.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#1,357
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026StoneX Group Inc. holds $35,939,835 across 13 Drug Manufacturers - General names. JNJ ranks #3 (19.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
32,707 | $8,230,389 | |
| 2 | LLY |
ELI LILLY & Co
|
6,635 | $7,958,218 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
27,201 | $6,908,237 | |
| 4 | MRK |
Merck & Co., Inc.
|
42,565 | $5,469,602 | |
| 5 | AMGN |
Amgen Inc
|
12,416 | $4,496,081 | |
| 6 | PFE |
Pfizer Inc
|
33,470 | $805,957 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,503 | $547,562 | |
| 8 | NVS |
Novartis AG
|
2,818 | $441,636 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,908,237 | 27,201 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $6,879,030 | 28,142 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $9,633,729 | 46,551 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $8,601,262 | 46,388 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,299,158 | 47,785 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $7,600,613 | 45,831 | Shares | Defined | 2025-08-13 | |
| 2024-12-31 | $6,227,481 | 43,061 | Shares | Defined | 2025-08-13 | |
| 2024-09-30 | $5,177,817 | 31,950 | Shares | Defined | 2025-08-13 | |
| 2024-06-30 | $4,516,051 | 30,898 | Shares | Defined | 2025-08-13 | |
| 2024-03-31 | $4,380,755 | 27,693 | Shares | Defined | 2025-08-13 | |
| 2023-12-31 | $3,721,477 | 23,743 | Shares | Defined | 2025-08-13 | |
| 2023-09-30 | $3,477,118 | 22,325 | Shares | Defined | 2025-08-13 | |
| 2023-06-30 | $3,725,193 | 22,506 | Shares | Defined | 2025-08-13 | |
| 2023-03-31 | $3,372,490 | 21,758 | Shares | Defined | 2025-08-13 | |
| 2022-12-31 | $3,540,066 | 20,040 | Shares | Defined | 2025-08-13 | |
| 2022-09-30 | $3,094,691 | 18,944 | Shares | Defined | 2025-08-13 | |
| 2022-06-30 | $3,154,352 | 17,770 | Shares | Defined | 2025-08-13 | |
| 2022-03-31 | $3,202,014 | 18,067 | Shares | Defined | 2025-08-13 | |
| 2021-12-31 | $2,920,335 | 17,071 | Shares | Defined | 2025-08-13 | |
| 2021-09-30 | $2,406,673 | 14,902 | Shares | Defined | 2021-10-20 | |
| 2021-06-30 | $2,528,100 | 15,346 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $2,314,541 | 14,083 | Shares | Defined | 2021-06-30 | |
| 2020-12-31 | $2,171,057 | 13,795 | Shares | Defined | 2021-02-03 | |
| 2020-09-30 | $1,884,671 | 12,659 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,577,306 | 11,216 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,317,463 | 10,047 | Shares | Defined | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||